Research ArticleAutism Spectrum Disorder

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism

See allHide authors and affiliations

Science Translational Medicine  08 May 2019:
Vol. 11, Issue 491, eaau7356
DOI: 10.1126/scitranslmed.aau7356

Article Information

vol. 11 no. 491

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 13, 2018
  • Resubmitted October 30, 2018
  • Accepted for publication January 26, 2019
  • .

Article Versions

Author Information

  1. Karen J. Parker1,*,
  2. Ozge Oztan1,
  3. Robin A. Libove1,
  4. Noreen Mohsin1,
  5. Debra S. Karhson1,
  6. Raena D. Sumiyoshi1,
  7. Jacqueline E. Summers1,
  8. Kyle E. Hinman1,
  9. Kara S. Motonaga2,
  10. Jennifer M. Phillips1,
  11. Dean S. Carson1,
  12. Lawrence K. Fung1,
  13. Joseph P. Garner1,3 and
  14. Antonio Y. Hardan1
  1. 1Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA.
  2. 2Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
  3. 3Department of Comparative Medicine, Stanford University, Stanford, CA 94305, USA.
  1. *Corresponding author. Email: kjparker{at}stanford.edu

Altmetric

Article usage

Article usage: April 2019 to September 2020

AbstractFullPdf
Apr 2019052
May 201971231112547
Jun 20194869155
Jul 20192684858
Aug 20192513738
Sep 20193007657
Oct 201921210690
Nov 20192152727
Dec 20191983337
Jan 20202524837
Feb 20201913447
Mar 20201792818
Apr 20201973151
May 20204820893
Jun 2020920771
Jul 2020315868
Aug 2020413650
Sep 20201014177

Stay Connected to Science Translational Medicine

Navigate This Article